PHP
INCY icon

Parkman Healthcare Partners’s Incyte INCY Stock Holding History

Parkman Healthcare Partners’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,442
Closed -$8.52M – 105
2025
Q3 		$8.52M Buy
100,442
+25,442
+34% +$2.01M 0.89% 41
2025
Q2 		$5.11M Buy
+75,000
New +$4.75M 0.59% 60

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parkman Healthcare Partners's INCY Position: Q4 2025 in Review

Parkman Healthcare Partners sold out of Incyte (INCY) in Q4 2025, closing a stake of 100,442 shares — an estimated $8.52M sold.

Parkman Healthcare Partners first reported a position in INCY in Q2 2025 and held it in 2 quarters. The position peaked at $8.52M in Q3 2025. 822 funds tracked by Wall St. Rank hold INCY as of Q4 2025.

  • Parkman Healthcare Partners reported no remaining Incyte position as of Q4 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,442 Incyte shares in Q4 2025, an estimated $8.52M.
  • Parkman Healthcare Partners first reported a position in Incyte in Q2 2025 and held it in 2 quarters.
  • Parkman Healthcare Partners's Incyte position peaked at $8.52M in Q3 2025.
  • 822 funds tracked by Wall St. Rank held Incyte as of Q4 2025.

Based on Parkman Healthcare Partners's 13F filing for Q4 2025, filed 17 Feb 2026.